Continue Reading
Full article on Yahoo Finance
Abbott Stock Slumps. The Nutrition Business Is a Drag on Earnings.
Market Intelligence Analysis
AI-Powered 90% GROQ-LLAMA-3.1-8B-INSTANT
Why This Matters
Abbott Laboratories' stock declined after the company's fourth-quarter earnings and sales fell short of Wall Street expectations, despite beating earnings per share estimates.
Market Impact
Market impact analysis based on bearish sentiment with 90% confidence.
Sentiment
Bearish
AI Confidence
90%
Time Horizon
Short Term
Article Context
Note: This is a brief excerpt for context. Click below to read the full article on the original source.
Shares of Abbott Laboratories tumbled on Thursday after the medical devices maker posted fourth-quarter earnings and sales that underwhelmed Wall Street. For the fourth quarter, Abbott reported adjusted earnings of $1.50 a share, slightly better than the $1.49 consensus among analysts tracked by FactSet The company logged roughly $11.5 billion in sales, missing the $11.8 billion analysts had forecast. The company said it expects full-year adjusted earnings in the range of $5.55 to $5.80 a share.
AI Breakdown
Summary
Abbott Laboratories' stock declined after the company's fourth-quarter earnings and sales fell short of Wall Street expectations, despite beating earnings per share estimates.
Market Impact
Market impact analysis based on bearish sentiment with 90% confidence.
Time Horizon
Short Term
Original article published by
Yahoo Finance
on January 22, 2026.
Analysis and insights provided by AnalystMarkets AI.
Analysis and insights provided by AnalystMarkets AI.